Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Caplin Steriles Gummidipoondi facility gets zero USFDA observations

Written By Ruchika Sharma10 Aug 2024 1:30 PM IST

Mumbai: Caplin Point Labs has announced that the United States Food and Drug Administration (US FDA) has concluded an unannounced inspection with...

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Lupin Australia arm incorporates new subsidiary in New Zealand

Written By Ruchika Sharma10 Aug 2024 11:00 AM IST

Mumbai: Through a recent BSE filing, Lupin has informed that Generic Health Pty Ltd., Australia, a wholly owned subsidiary of the Company, has...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

Zydus Lifesciences bags USFDA nod for tardive dyskinesia drug Valbenazine

Written By Ruchika Sharma9 Aug 2024 3:03 PM IST

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market...

Liquid drugs worth Rs 831 crore seized from Thane, Bharuch

Written By Ruchika Sharma9 Aug 2024 12:30 PM IST

Ahmedabad: In a major crackdown, the Gujarat Anti-Terrorist Squad (ATS) raided a mephedrone manufacturing unit in Thane district of...

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

Shilpa Medicare successfully completes Phase 1 clinical trial for Recombinant Human Albumin 20%

Written By Ruchika Sharma8 Aug 2024 4:21 PM IST

Karnataka: Shilpa Medicare Limited has announced the successful completion of its Phase 1 clinical trial for recombinant human albumin 20%...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

USFDA nod to Caplin Steriles Timolol Maleate Ophthalmic Solution

Written By Ruchika Sharma8 Aug 2024 1:15 PM IST

Chennai: Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval by the United States...

Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy Pipeline

Novartis bags USFDA accelerated approval for Fabhalta for reduction of proteinuria in primary IgA nephropathy

Written By Ruchika Sharma8 Aug 2024 11:30 AM IST

Basel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Fabhalta (iptacopan), a...

USFDA nod to Alembic Pharma Acitretin capsules for severe psoriasis

Written By Ruchika Sharma7 Aug 2024 5:15 PM IST

Acitretin capsules are indicated for the treatment of severe psoriasis in adults.

Lupin and TB Alliance Join Forces to Advance Telacebec

Lupin incorporates new subsidiary Lupin Lanka in Sri Lanka

Written By Ruchika Sharma7 Aug 2024 1:58 PM IST

Mumbai: Lupin Ltd. has incorporated Lupin Lanka (Private) Ltd., Sri Lanka, as wholly owned subsidiary of the Company.The Company will make...

Aurobindo Pharma secures USFDA okay for generic version of Novo Nordisk Vagifem

Written By Ruchika Sharma7 Aug 2024 11:30 AM IST

Hyderabad: Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to...

Lupin completes Phase 3 trials for Lucentis biosimilar

Written By Ruchika Sharma6 Aug 2024 4:30 PM IST

Mumbai: Global Pharma major Lupin Limited has announced the successful completion of a global Phase 3 clinical study of LUBT010, its biosimilar...

Himachal Govt to provide 42 medicines free of cost to cancer patients in govt hospitals

Written By Ruchika Sharma6 Aug 2024 3:49 PM IST

Shimla: Chief Minister Thakur Sukhvinder Singh Sukhu has announced that free of cost treatment and free medicines will be provided to cancer patients...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok